Staphylococcus capitis

Last updated

Staphylococcus capitis
CSF S capitis 2013-11-08.JPG
Staphylococcus capitis in cerebrospinal fluid.
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Bacillota
Class: Bacilli
Order: Bacillales
Family: Staphylococcaceae
Genus: Staphylococcus
Species:
S. capitis
Binomial name
Staphylococcus capitis
Kloos and Schleifer 1975 (Approved Lists 1980)

Staphylococcus capitis is a coagulase-negative species (CoNS) of Staphylococcus . It is part of the normal flora of the skin of the human scalp, face, neck, scrotum, and ears and has been associated with prosthetic valve endocarditis, but is rarely associated with native valve infection. [1]

Contents

Microbiology

Staphylococcus capitis is a bacteria that colonizes the skin, scalp, face and neck. [2] Staphylococcus capitis typically colonises the skin of the head (especially the ears and forehead), arms, and, sometimes, legs. According to one study, head and arm populations of S. capitis persisted over the course of one year in 20% of individuals. Staphylococcus capitis species has two subspecies: subsp. urealyticus, and subsp. capitis; both may become pathogenic in humans. During antibiotic therapy, the former (but not the latter) expands its distribution beyond the head. [3]

Morphology

Staphylococcus capitis was originally detected in human skin in 1975 and categorized as a coagulase negative staphylococci (CoNS) species. Staphylococcus capitis bacteria preferentially dwell on the skin and mucous membranes of humans and other warm-blooded animals. Warm-blooded creatures provide a very conducive environment for bacteria to grow, since the ideal temperature for bacteria to thrive is between 30 and 37 degrees Celsius. They are tolerated by the human immune system when applied to the skin. Because of their inept behavior, they must be translated. Bacteria are spherical cells 0.5 to 1.5 µm in diameter, not rod-shaped. Staphylococci are incapable of active movement and are organized singly, in pairs, or in grape-like clusters. All staphylococci develop anaerobically on one side. That is, they can metabolize even when there is no oxygen present. However, when oxygen is available in their surroundings, their metabolism becomes active. [4] Staphylococcus capitis TE8 was isolated from the skin surface of a healthy adult foot and found to have potent antibacterial action against Gram-positive bacteria such as Staphylococcus aureus. [5] Staphylococcus is a gram-positive bacterial spherule. Some staphylococci are capable of producing free coagulase. Thus, that is used to differentiate Staphylococcus species. In this context, a distinction is made in species between coagulase-positive and coagulase-negative staphylococci. Staphylococcus capitis is a species in the genus that is positive for staph coagulase. [6]

Research

Methods

Shotgun and paired-end pyrosequencing were one of the technique using to study the genome of S. capitis. Researchers get a 109-fold coverage of the whole genome of S. capitis. The clinical and subclinical isolates are found in a broad variety of clades and do not exhibit any evident link, according to analysis of the 16S RNA genes from the genome sequences of Staphylococcus spp. from bovine and buffalo mastitis cases. [5]

Genomics

Staphylococcus capitis is a coagulase-negative staphylococci opportunistic pathogen (CoNS). S. capitis was described as the absence of accessible full genome sequences in S. capitis functional genomic investigations was restricted to this day. S. capitis' connections with S. epidermidis are more evolutionarily than other clinically important negative coagulase staphylococcus. The smallest genome among the closed genomes sequenced to date is S. capitis with the least expected CDS.  The paucity of full genome sequences for S. capitis has hampered functional genomic investigations thus far. Other therapeutically relevant coagulase negative staphylococci have closer evolutionary ties to S. epidermidis than S. capitis. There are 2304 protein-coding DNA sequences predicted on the chromosome, six rRNA operons, 63 tRNA genes, and a single tmRNA gene. With the fewest projected CDS of all closed staphylococcal genomes sequenced to date, S. capitis has the smallest genome of all closed staphylococcal genomes sequenced to date. Proteases like ClpP in S. Capitis, which helps create biofilms, and SepA, which has been demonstrated to degrade host antimicrobial peptides in CoNS, as well as hemolysins, lipases, and esterases, are among them. In contrast to the acute illness enabled by conventional exoproteins of the more virulent staphylococcal species, S. aureus, these proteins are expected to facilitate immune evasion, host colonization, and persistence. [7]

Staphylococci are organized individually, in pairs or clusters similar to grapes, and cannot be actively migrated. All staphylococci are anaerobic unilaterally growing. They have catalase instead of oxidase: an enzyme that turns hydrogen peroxide in oxygen and water into energy. As the information written above is based on the phylogeny of S. Capitis, this can be listed into an evolution relationship section that briefly describes their morphology and how they were found to be related to other Staph families. [7]

Evolution

This bacterium’s evolution through genome expression in very detail and in comparison with other relatives of the Staphylococci as well with experiments and data that have been collected in the past. S. capitis’ genomes with a deeper understanding of this species and how evolutionary related it is to other Bacterium (S. capitis has a closer evolutionary link to S. epidermidis than other clinically relevant coagulase negative staphylococci), we could discover with more information whether this species' cause of the disease is connected to other species. [7] Although they cause different pathogenic virulence, they have many similar features in their genetics and morphology. The main causes of nosocomial infections, in particular nosocomial bacteremias, have emerged as coagulase-negative staphylococci (CoNS). The capacity to produce biofilm from implanted equipment surfaces is CoNS's most significant mechanism for pathogenicity. Starting very early, research into biofilm formation in Staphylococcus epidermidis has served as a model for other staphylococci such as Staphylococcus aureus and other CoNS species. Moreover, data also showed that S. capitis have a strain (AYP1020) that researchers use to general genomic characteristics compared to S. epidermidis’ strain (RP62a). Thus, in comparison study, S. epidermidis (RP62a) was identified as a near related with S. capitis and as the therapeutically highly significant coagulase-negative staphylococci (CoNS). This source showed very detailed studies of S. Capitis’ relationship among its Staph families highlighting clearly the significance between itself and S. epidermidis. [8]

Role in disease

Although bacteria of the species Staphylococcus capitis are a natural element of human flora, they may become pathogenic in immunocompromised patients [7] [2] who might develop poisoning symptoms[ further explanation needed ] and endocarditis as a result of microorganisms entering the body. [2]

S. capitis has been linked to peritoneal dialysis peritonitis, prosthetic-valve endocarditis, pacemaker endocarditis, meningitis, acetabulum osteomyelitis, and spondylodiscitis, according to case reports. It's also a well-known pathogen in neonatal sepsis, where genetic fingerprinting has shown its ability for clonal nosocomial dissemination; [3] S. capitis may cause late-onset sepsis in pre-term neonates, possibly by first colonising the immature - and consequently more permeable - neonatal gut before entering the bloodstream from the gut. [9] It is known to cause infection surrounding prosthetic devices, as is the case with other CoNS. It is infrequently recognized as a cause of endocarditis. [10]

CoNS produce a slimy biofilm enabling them to adhere to medical devices such as prosthetic valves and catheters and makes them difficult to remove by patient immune response to antibiotic therapy. As native flora of the skin and mucous membranes, they may be introduced anytime these are punctured, i.e. at the time of device placement, venipuncture, or through breaks in the mucous membrane or skin. CoNS species, such as S. epidermidis and S. capitis, are recorded as the most common cause of prosthetic valve endocarditis. [11] [12] [13]

Staphylococcus capitis, fortunately, has a lower propensity to antibiotic resistance and also produces less biofilm than many other CoNS. This improves chances of successful eradication of S. capitis in periprosthetic infections (as total knee and total hip arthroplasty infections) relative to other CoNS such as S. epidermidis. [14]

It can be sampled from prosthetic joint infections, most likely contracted from surgery. It can readily spread in the hospital environment, necessitating awareness and proper measures to curb spread. [15]

Antibiotic resistance

S. capitis may exhibit multidrug resistance, including to methicillin, and fluoroquinolone. [3]

Related Research Articles

<i>Staphylococcus aureus</i> Species of Gram-positive bacterium

Staphylococcus aureus is a Gram-positive spherically shaped bacterium, a member of the Bacillota, and is a usual member of the microbiota of the body, frequently found in the upper respiratory tract and on the skin. It is often positive for catalase and nitrate reduction and is a facultative anaerobe that can grow without the need for oxygen. Although S. aureus usually acts as a commensal of the human microbiota, it can also become an opportunistic pathogen, being a common cause of skin infections including abscesses, respiratory infections such as sinusitis, and food poisoning. Pathogenic strains often promote infections by producing virulence factors such as potent protein toxins, and the expression of a cell-surface protein that binds and inactivates antibodies. S. aureus is one of the leading pathogens for deaths associated with antimicrobial resistance and the emergence of antibiotic-resistant strains, such as methicillin-resistant S. aureus (MRSA), is a worldwide problem in clinical medicine. Despite much research and development, no vaccine for S. aureus has been approved.

Bloodstream infections (BSIs) are infections of blood caused by blood-borne pathogens. Blood is normally a sterile environment, so the detection of microbes in the blood is always abnormal. A bloodstream infection is different from sepsis, which is characterized by severe inflammatory or immune responses of the host organism to pathogens.

<span class="mw-page-title-main">Septic arthritis</span> Medical condition

Acute septic arthritis, infectious arthritis, suppurative arthritis, pyogenic arthritis, osteomyelitis, or joint infection is the invasion of a joint by an infectious agent resulting in joint inflammation. Generally speaking, symptoms typically include redness, heat and pain in a single joint associated with a decreased ability to move the joint. Onset is usually rapid. Other symptoms may include fever, weakness and headache. Occasionally, more than one joint may be involved, especially in neonates, younger children and immunocompromised individuals. In neonates, infants during the first year of life, and toddlers, the signs and symptoms of septic arthritis can be deceptive and mimic other infectious and non-infectious disorders.

<span class="mw-page-title-main">Coagulase</span> Class of bacterial proteins

Coagulase is a protein enzyme produced by several microorganisms that enables the conversion of fibrinogen to fibrin. In the laboratory, it is used to distinguish between different types of Staphylococcus isolates. Importantly, S. aureus is generally coagulase-positive, meaning that a positive coagulase test would indicate the presence of S. aureus or any of the other 11 coagulase-positive Staphylococci. A negative coagulase test would instead show the presence of coagulase-negative organisms such as S. epidermidis or S. saprophyticus. However, it is now known that not all S. aureus are coagulase-positive. Whereas coagulase-positive Staphylococci are usually pathogenic, coagulase-negative Staphylococci are more often associated with opportunistic infection.

Staphylococcus lugdunensis is a coagulase-negative member of the genus Staphylococcus, consisting of Gram-positive bacteria with spherical cells that appear in clusters.

<i>Staphylococcus haemolyticus</i> Species of bacterium

Staphylococcus haemolyticus is a member of the coagulase-negative staphylococci (CoNS). It is part of the skin flora of humans, and its largest populations are usually found at the axillae, perineum, and inguinal areas. S. haemolyticus also colonizes primates and domestic animals. It is a well-known opportunistic pathogen, and is the second-most frequently isolated CoNS. Infections can be localized or systemic, and are often associated with the insertion of medical devices. The highly antibiotic-resistant phenotype and ability to form biofilms make S. haemolyticus a difficult pathogen to treat. Its most closely related species is Staphylococcus borealis.

<i>Staphylococcus saprophyticus</i> Species of bacterium

Staphylococcus saprophyticus is a Gram-positive coccus belonging to the genus Staphylococcus. S. saprophyticus is a common cause of community-acquired urinary tract infections.

Staphylococcus caprae is a Gram-positive, coccus bacteria and a member of the genus Staphylococcus. S. caprae is coagulase-negative. It was originally isolated from goats, but members of this species have also been isolated from human samples.

Staphylococcus hominis is a coagulase-negative member of the bacterial genus Staphylococcus, consisting of Gram-positive, spherical cells in clusters. It occurs very commonly as a harmless commensal on human and animal skin and is known for producing thioalcohol compounds that contribute to body odour. Like many other coagulase-negative staphylococci, S. hominis may occasionally cause infection in patients whose immune systems are compromised, for example by chemotherapy or predisposing illness.

Staphylococcus warneri is a member of the bacterial genus Staphylococcus, consisting of Gram-positive bacteria with spherical cells appearing in clusters. It is catalase-positive, oxidase-negative, and coagulase-negative, and is a common commensal organism found as part of the skin flora on humans and animals. Like other coagulase-negative staphylococci, S. warneri rarely causes disease, but may occasionally cause infection in patients whose immune system is compromised.

<i>Staphylococcus epidermidis</i> Species of bacterium

Staphylococcus epidermidis is a Gram-positive bacterium, and one of over 40 species belonging to the genus Staphylococcus. It is part of the normal human microbiota, typically the skin microbiota, and less commonly the mucosal microbiota and also found in marine sponges. It is a facultative anaerobic bacteria. Although S. epidermidis is not usually pathogenic, patients with compromised immune systems are at risk of developing infection. These infections are generally hospital-acquired. S. epidermidis is a particular concern for people with catheters or other surgical implants because it is known to form biofilms that grow on these devices. Being part of the normal skin microbiota, S. epidermidis is a frequent contaminant of specimens sent to the diagnostic laboratory.

<span class="mw-page-title-main">Oritavancin</span> Pharmaceutical drug

Oritavancin, sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin.

Lysostaphin is a Staphylococcus simulans metalloendopeptidase. It can function as a bacteriocin (antimicrobial) against Staphylococcus aureus.

<span class="mw-page-title-main">Staphylococcal infection</span> Medical condition

A staphylococcal infection or staph infection is an infection caused by members of the Staphylococcus genus of bacteria.

<i>Staphylococcus</i> Genus of Gram-positive bacteria

Staphylococcus is a genus of Gram-positive bacteria in the family Staphylococcaceae from the order Bacillales. Under the microscope, they appear spherical (cocci), and form in grape-like clusters. Staphylococcus species are facultative anaerobic organisms.

<i>Staphylococcus hyicus</i> Species of bacterium

Staphylococcus hyicus is a Gram-positive, facultatively anaerobic bacterium in the genus Staphylococcus. It consists of clustered cocci and forms white circular colonies when grown on blood agar. S. hyicus is a known animal pathogen. It causes disease in poultry, cattle, horses, and pigs. Most notably, it is the agent that causes porcine exudative epidermitis, also known as greasy pig disease, in piglets. S. hyicus is generally considered to not be zoonotic, however it has been shown to be able to cause bacteremia and sepsis in humans.

Staphylococcus schleiferi is a Gram-positive, cocci-shaped bacterium of the family Staphylococcaceae. It is facultatively anaerobic, coagulase-variable, and can be readily cultured on blood agar where the bacterium tends to form opaque, non-pigmented colonies and beta (β) hemolysis. There exists two subspecies under the species S. schleiferi: Staphylococcus schleiferi subsp. schleiferi and Staphylococcus schleiferi subsp. coagulans.

Staphylococcus pseudintermedius is a gram positive coccus bacteria of the genus Staphylococcus found worldwide. It is primarily a pathogen for domestic animals, but has been known to affect humans as well. S. pseudintermedius is an opportunistic pathogen that secretes immune modulating virulence factors, has many adhesion factors, and the potential to create biofilms, all of which help to determine the pathogenicity of the bacterium. Diagnoses of Staphylococcus pseudintermedius have traditionally been made using cytology, plating, and biochemical tests. More recently, molecular technologies like MALDI-TOF, DNA hybridization and PCR have become preferred over biochemical tests for their more rapid and accurate identifications. This includes the identification and diagnosis of antibiotic resistant strains.

<span class="mw-page-title-main">Georg Peters</span> German physician

Georg Peters was a German physician, microbiologist and university professor. From 1992 until his fatal mountain accident he headed the Institute of Medical Microbiology at the University of Münster. He was an internationally recognised expert in the field of staphylococci and the infectious diseases caused by them, to which he had devoted himself since the beginning of his scientific career.

Kerry L. LaPlante is an American pharmacist, academic and researcher. She is the Dean at the University of Rhode Island College of Pharmacy. She is a Professor of Pharmacy and former department Chair of the Department of Pharmacy Practice at the University of Rhode Island, an Adjunct Professor of Medicine at Brown University, an Infectious Diseases Pharmacotherapy Specialist, and the Director of the Rhode Island Infectious Diseases Fellowship and Research Programs at the Veterans Affairs Medical Center in Providence, Rhode Island.

References

  1. Kloos, W. E.; Schleifer, K. H. (1975). "Isolation and Characterization of Staphylococci from Human Skin II. Descriptions of Four New Species: Staphylococcus warneri, Staphylococcus capitis, Staphylococcus hominis, and Staphylococcus simulans". International Journal of Systematic Bacteriology. 25 (1): 62–79. doi: 10.1099/00207713-25-1-62 . ISSN   0020-7713.
  2. 1 2 3 Kloos, Wesley E. (1981), Maibach, Howard I.; Aly, Raza (eds.), "The Identification of Staphylococcus and Micrococcus Species Isolated from Human Skin", Skin Microbiology, New York, NY: Springer US, pp. 3–12, doi:10.1007/978-1-4612-5868-1_1, ISBN   978-1-4612-5870-4 , retrieved 2021-12-13
  3. 1 2 3 Tevell, S.; Hellmark, B.; Nilsdotter-Augustinsson, Å.; Söderquist, B. (January 2017). "Staphylococcus capitis isolated from prosthetic joint infections". European Journal of Clinical Microbiology & Infectious Diseases. 36 (1): 115–122. doi:10.1007/s10096-016-2777-7. ISSN   0934-9723. PMC   5203848 . PMID   27680718.
  4. Otto, Michael (April 2010). "Staphylococcus colonization of the skin and antimicrobial peptides". Expert Review of Dermatology. 5 (2): 183–195. doi:10.1586/edm.10.6. ISSN   1746-9872. PMC   2867359 . PMID   20473345.
  5. 1 2 Pizauro, Lucas José Luduverio; de Almeida, Camila Chioda; Silva, Saura Rodrigues; MacInnes, Janet I.; Kropinski, Andrew M.; Zafalon, Luiz Francisco; de Avila, Fernando Antônio; de Mello Varani, Alessandro (December 2021). "Genomic comparisons and phylogenetic analysis of mastitis-related staphylococci with a focus on adhesion, biofilm, and related regulatory genes". Scientific Reports. 11 (1): 17392. Bibcode:2021NatSR..1117392P. doi:10.1038/s41598-021-96842-2. ISSN   2045-2322. PMC   8405628 . PMID   34462461.
  6. DEVRIESE, L.A.; SCHLEIFER, K.H.; ADEGOKE, G.O. (January 1985). "Identification of coagulase-negative staphylococci from farm animals". Journal of Applied Bacteriology. 58 (1): 45–55. doi:10.1111/j.1365-2672.1985.tb01428.x. ISSN   0021-8847. PMID   3980296.
  7. 1 2 3 4 Cameron, David R.; Jiang, Jhih-Hang; Hassan, Karl A.; Elbourne, Liam D. H.; Tuck, Kellie L.; Paulsen, Ian T.; Peleg, Anton Y. (2015-09-23). "Insights on virulence from the complete genome of Staphylococcus capitis". Frontiers in Microbiology. 6: 980. doi: 10.3389/fmicb.2015.00980 . ISSN   1664-302X. PMC   4585213 . PMID   26441910.
  8. Cui, Bintao; Smooker, Peter M.; Rouch, Duncan A.; Daley, Andrew J.; Deighton, Margaret A. (January 2013). "Differences between Two Clinical Staphylococcus capitis Subspecies as Revealed by Biofilm, Antibiotic Resistance, and Pulsed-Field Gel Electrophoresis Profiling". Journal of Clinical Microbiology. 51 (1): 9–14. doi:10.1128/JCM.05124-11. ISSN   0095-1137. PMC   3536240 . PMID   23052315.
  9. Butin, M.; Rasigade, J.-P.; Subtil, F.; Martins-Simões, P.; Pralong, C.; Freydière, A.-M.; Vandenesch, F.; Tigaud, S.; Picaud, J.-C.; Laurent, F. (November 2017). "Vancomycin treatment is a risk factor for vancomycin-nonsusceptible Staphylococcus capitis sepsis in preterm neonates". Clinical Microbiology and Infection. 23 (11): 839–844. doi: 10.1016/j.cmi.2017.03.022 . PMID   28373147.
  10. Sandoe, J A T; Kerr, K G; Reynolds, G W; Jain, S (1999-09-01). "Staphylococcus capitis endocarditis: two cases and review of the literature". Heart. 82 (3): e1. doi:10.1136/hrt.82.3.e1. ISSN   1355-6037. PMC   1729175 . PMID   10455099.
  11. Van Der Zwet WC, Debets-Ossenkopp YJ, Reinders E, et al. (July 2002). "Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit". J. Clin. Microbiol. 40 (7): 2520–5. doi:10.1128/JCM.40.7.2520-2525.2002. PMC   120592 . PMID   12089273.
  12. D'mello D, Daley AJ, Rahman MS, et al. (September 2008). "Vancomycin heteroresistance in bloodstream isolates of Staphylococcus capitis". J. Clin. Microbiol. 46 (9): 3124–6. doi:10.1128/JCM.00592-08. PMC   2546727 . PMID   18596138.
  13. Iwase T, Seki K, Shinji H, Mizunoe Y, Masuda S (October 2007). "Development of a real-time PCR assay for the detection and identification of Staphylococcus capitis, Staphylococcus haemolyticus and Staphylococcus warneri". J. Med. Microbiol. 56 (Pt 10): 1346–9. doi: 10.1099/jmm.0.47235-0 . PMID   17893172.
  14. Kloos WE PMC   358308, Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev. 1994 Jan; 7(1): 117–140
  15. Tevell, S.; Hellmark, B.; Nilsdotter-Augustinsson, Å.; Söderquist, B. (2017). "Staphylococcus capitis isolated from prosthetic joint infections". European Journal of Clinical Microbiology & Infectious Diseases. 36 (1): 115–122. doi:10.1007/s10096-016-2777-7. PMC   5203848 . PMID   27680718.